|
LantusDrug - Lantus The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Insulin Glargine Recombinant
Strength -
100 UNITS/ML
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
021081
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 20, 2000
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Aventis Pharmaceuticals Inc
Lantus
Indomethegan 50mg Suppository; Rectal
Indocin 25mg/5ml Suspension; Oral Indomethacin 25mg/5ml Suspension; Oral Indocin I.V. Eq 1mg Base/vial Injectable; Injection Novolog Mix 70/30 70 Units/ml;30 Units/ml Injectable; Subcutaneous Novolog 100 Units/ml Injectable; Subcutaneous Levemir 100 Units/ml Injectable; Subcutaneous Lantus 100 Units/ml Injectable; Injection Indomethacin 50mg Capsule; Oral Indocin 50mg Suppository; Rectal NewDrugInformation |